Patent ID: 7879814

Claim:
A method for treating advanced, non-resectable cancer by administering to a human patient in need thereof in an out-patient setting an effective amount of a member selected from the group consisting of a mixture of adenosine and inorganic phosphate; adenosine 5′-monophosphate (AMP); adenosine 5′-diphosphate (ADP); adenosine 5′-triphosphate (ATP); a pharmaceutically acceptable salt of the mixture of adenosine and inorganic phosphate; a chelate of the mixture of adenosine and inorganic phosphate; a metal complex of the mixture of adenosine and inorganic phosphate; a liposome of the mixture of adenosine and inorganic phosphate; a pharmaceutically acceptable salt of adenosine 5′-monophosphate (AMP); a chelate of adenosine 5′-monophosphate (AMP); a metal complex of adenosine 5′-monophosphate (AMP); a liposome of adenosine 5′-monophosphate (AMP); a pharmaceutically acceptable salt of adenosine 5′-diphosphate (ADP); a chelate of adenosine 5′-diphosphate (ADP); a metal complex of adenosine 5′-diphosphate (ADP); a liposome of adenosine 5′-diphosphate (ADP); a pharmaceutically acceptable salt of adenosine 5′-triphosphate (ATP); a chelate of adenosine 5′-triphosphate (ATP); a metal complex of adenosine 5′-triphosphate (ATP); and a liposome of adenosine 5′-triphosphate (ATP); or a mixture thereof.